scispace - formally typeset
D

Douglas B. Kell

Researcher at University of Liverpool

Publications -  657
Citations -  55792

Douglas B. Kell is an academic researcher from University of Liverpool. The author has contributed to research in topics: Systems biology & Dielectric. The author has an hindex of 111, co-authored 634 publications receiving 50335 citations. Previous affiliations of Douglas B. Kell include Max Planck Society & University of Wales.

Papers
More filters
Journal ArticleDOI

Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets

TL;DR: Three workflows have been developed to allow for the rapid, automated and high-throughput annotation and putative metabolite identification of electrospray LC-MS-derived metabolomic datasets.
Journal ArticleDOI

SBML Level 3: an extensible format for the exchange and reuse of biological models

Sarah M. Keating, +146 more
TL;DR: The latest edition of the Systems Biology Markup Language (SBML) is reviewed, a format designed for this purpose that leverages two decades of SBML and a rich software ecosystem that transformed how systems biologists build and interact with models.
Journal ArticleDOI

The estimation of microbial biomass

TL;DR: Methods that have been used to estimate the content, and in some cases the nature, of the microbial biomass in a sample are reviewed.

Metabolic control theory: its role in microbiology and biotechnology (Flux control; optimisation; elasticity; concentration control; productivity; metabolism; genetic engineering)

TL;DR: The metabolic control theory developed by Kacser, Burns, Heinrich and Rapoport can provide a rational and quantitative basis for the description and improvement of such processes.
Journal ArticleDOI

The rpf gene of Micrococcus luteus encodes an essential secreted growth factor

TL;DR: Rpf is the first example of a truly secreted protein that is essential for bacterial growth, and if the Rpf‐like proteins elaborated by Mycobacterium tuberculosis and other mycobacteria prove similarly essential, interference with their proper functioning may offer novel opportunities for protecting against, and treating, tuberculosis.